Cytomab 500mg (Rituximab Vials) 500mg/50ml

Cytomab 500mg is a rituximab biosimilar used to treat autoimmune conditions and certain cancers. This 500mg/50ml vial form is stored at 2-8°C and manufactured by Alkem Laboratories. A monoclonal antibody therapy option for immune-related disorders.

Strength

500mg/50ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Alkem Laboratories Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cytomab 500mg is used to treat autoimmune diseases like rheumatoid arthritis and certain types of blood cancers such as non-Hodgkin lymphoma. It works by targeting CD20-positive B-cells, helping reduce inflammation and abnormal cell growth. Patients often ask what Cytomab 500mg is used for in managing chronic conditions.

Side Effects

Cytomab 500mg may help reduce symptoms of autoimmune disorders by lowering immune system activity. Some users report improved mobility and reduced pain after treatment. Common effects include infusion-related reactions, which are typically managed under medical supervision.

Precautions & Warnings

Cytomab 500mg should be handled by healthcare professionals in a clinical setting. Patients must inform their doctor about infections, heart conditions, or previous reactions to biologics. Regular monitoring is recommended during and after administration.

Avoid Interactions

Cytomab 500mg may interact with other immunosuppressants or live vaccines. Alcohol and certain medications can affect how the body processes this therapy. Always disclose all medications to your healthcare provider before starting treatment.

Frequently Asked Questions

Cytomab 500mg is used to treat autoimmune diseases like rheumatoid arthritis and certain blood cancers such as non-Hodgkin lymphoma.

Cytomab 500mg is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects include infusion-related reactions like fever, chills, or fatigue. These are typically managed during administration.

Cytomab 500mg is a prescription medication and should be obtained through licensed pharmacies or healthcare providers.

Cytomab 500mg should be stored at 2-8°C and protected from light until use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.